Medications for Alagille Syndrome
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Alagille Syndrome.
Found 2 Approved Drugs for Alagille Syndrome
Livmarli
Generic Name
Maralixibat
Livmarli
Generic Name
Maralixibat
Form: Tablet, Solution
Method of administration: Oral
FDA approval date: September 29, 2021
Classification: Ileal Bile Acid Transporter Inhibitor
LIVMARLI is an ileal bile acid transporter (IBAT) inhibitor indicated for: the treatment of cholestatic pruritus in patients 3 months of age and older with Alagille syndrome (ALGS).
Bylvay
Generic Name
Odevixibat
Bylvay
Generic Name
Odevixibat
Form: Capsule
Method of administration: Oral
FDA approval date: July 20, 2021
Classification: Ileal Bile Acid Transporter Inhibitor
BYLVAY is an ileal bile acid transporter (IBAT) inhibitor indicated for: Progressive Familial Intrahepatic Cholestasis (PFIC) the treatment of pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC).
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances